Lamotrigine Tablet, Film Coated, Extended Release
Product Images NDC 31722-244

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 31722-244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg Tab (100mg Picture)

The image shows a round, white film-coated tablet imprinted with "Y33" on one side. This tablet corresponds to lamotrigine extended-release. The imprint helps identify the medication, which is orally administered in extended-release tablet form, distributed by Camber Pharmaceuticals Inc.*

FDA Label Image

200 mg Tab (200mg Picture)

Lamotrigine extended-release 100 mg film-coated tablet with imprint 'Y34' on one side. Circular white tablet used for oral administration. Manufactured by Camber Pharmaceuticals Inc.*

FDA Label Image

250 mg Tab (250mg Picture)

The image shows an oval, film-coated extended-release tablet embossed with "Y35" on one side. This tablet corresponds to lamotrigine extended-release, a prescription oral medication available in various strengths including 100 mg and 200 mg, manufactured by Camber Pharmaceuticals Inc.*

FDA Label Image

25 mg Tab (25mg Picture)

The image shows a round, white extended-release film-coated tablet imprinted with 'Y31'. This tablet corresponds to lamotrigine extended-release oral tablets manufactured by Camber Pharmaceuticals Inc. Strength or other specifics are not visible on the tablet itself in the image.*

FDA Label Image

300 mg Tab (300mg Picture)

The image shows a white, oval, film-coated extended-release tablet with the imprint "Y36". This tablet corresponds to lamotrigine extended-release, available in various strengths including 100 mg, 200 mg, 25 mg, 250 mg, 300 mg, and 50 mg, and is labeled by Camber Pharmaceuticals Inc.*

FDA Label Image

50 mg Tab (50mg Picture)

The image shows a round, white, film-coated extended-release tablet of lamotrigine with the imprint "Y32". This tablet is identifiable as one of the available strengths for lamotrigine extended-release, a prescription drug by Camber Pharmaceuticals Inc., intended for oral use.*

FDA Label Image

Figure 1. Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (primary Generalized Tonic-clonic Seizures Study) (Figure 1)

A responder rate curve comparing lamotrigine extended-release and placebo. The graph shows the percentage of patients on the x-axis against responder rate (equal or greater improvement vs worsening) on the y-axis. Two lines represent the treatment group (lamotrigine) and placebo, showing differences in patient response rates.*

FDA Label Image

Figure 2. Proportion Of Patients By Responder Rate For Lamotrigine And Placebo Group (partial-onset Seizure Study) (Figure 2)

A line graph comparing responder rates between lamotrigine extended-release and placebo groups. The x-axis shows percent of patients from 100 to 0, and the y-axis shows responder rate from worsening (-100%) to improvement (100%). Two lines represent placebo (dashed) and lamotrigine (solid) response rates, illustrating treatment effects in a patient population.*

FDA Label Image

Chemical Structure (Graphic 01)

Chemical structure diagram of lamotrigine, showing the molecular arrangement with chlorine atoms, amino groups, and a fused ring system.*

FDA Label Image

Label-100mg30tablets (Label 100mg30tablets)

Label for lamotrigine extended-release tablets, USP, 100 mg, film-coated oral tablets. The label, manufactured for Camber Pharmaceuticals Inc, displays storage instructions, caution to verify product dispensed, and that 30 tablets are included. It features a barcode and manufacturing details including Yiling Pharmaceutical Ltd, China.*

FDA Label Image

Label-200mg30tablets (Label 200mg30tablets)

Lamotrigine Extended-Release Tablets USP 200 mg label from Camber Pharmaceuticals Inc. The label displays the drug name and strength prominently, notes the dosage form as extended-release tablets, and indicates a quantity of 30 tablets. It includes storage instructions, a caution to verify the product dispensed, and manufacturing information listing Camber Pharmaceuticals Inc. in Piscataway, NJ, and Yiling Pharmaceutical Ltd. in China. A barcode and revision date of June 2022 are also shown.*

FDA Label Image

Label-250mg30tablets (Label 250mg30tablets)

Label for Lamotrigine Extended-Release Tablets, USP 250 mg by Camber Pharmaceuticals Inc. The label indicates a 30-tablet pack, oral extended-release film-coated tablets, with storage instructions and a caution to verify the product dispensed and provide a medication guide. Manufactured in China for Camber Pharmaceuticals, New Jersey.*

FDA Label Image

Label-25mg30tablets (Label 25mg30tablets)

Lamotrigine Extended-Release Tablets, USP 25 mg film-coated tablets in a 30-tablet package by Camber Pharmaceuticals Inc. The label includes storage instructions, caution to verify product dispensed, and directions to dispense the medication guide. Manufactured by Yiling Pharmaceutical Ltd, China, and distributed by Camber Pharmaceuticals in Piscataway, NJ.*

FDA Label Image

Label-300mg30tablets (Label 300mg30tablets)

Lamotrigine Extended-Release Tablets, USP 300 mg film-coated tablet label by Camber Pharmaceuticals Inc. The label states 'CAUTION: Verify Product Dispensed' and 'Dispense the accompanying Medication Guide to each patient.' It indicates a dispensing quantity of 30 tablets, to be taken once a day, with storage instructions and manufacturing information included. A barcode and NDC 31722-245-30 are visible.*

FDA Label Image

Label-50mg30tablets (Label 50mg30tablets)

Lamotrigine Extended-Release Tablets, USP 50 mg film-coated extended-release oral tablets labeled by Camber Pharmaceuticals Inc. The carton contains 30 tablets. The label includes storage instructions, caution to verify the product dispensed, and a reminder to provide the Medication Guide with each prescription. Manufacturing information for Camber Pharmaceuticals, Inc. and Yiling Pharmaceutical Ltd is also noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.